论文部分内容阅读
血栓前状态分子标志物的检测正日益应用于临床 ,它不仅有利于血栓性疾病的早期诊断 ,同时还可作为溶栓治疗监测及预后的评价
The detection of prethrombotic state molecular markers is increasingly being used clinically, which is not only beneficial to the early diagnosis of thrombotic diseases, but also can be used as an evaluation of thrombolytic therapy monitoring and prognosis